VHHs as tools for therapeutic protein delivery to the central nervous system

Abstract Background The blood brain barrier (BBB) limits the therapeutic perspective for central nervous system (CNS) disorders. Previously we found an anti-mouse transferrin receptor (TfR) VHH (Nb62) that was able to deliver a biologically active neuropeptide into the CNS in mice. Here, we aimed to...

Full description

Bibliographic Details
Main Authors: Yessica Wouters, Tom Jaspers, Laura Rué, Lutgarde Serneels, Bart De Strooper, Maarten Dewilde
Format: Article
Language:English
Published: BMC 2022-10-01
Series:Fluids and Barriers of the CNS
Subjects:
Online Access:https://doi.org/10.1186/s12987-022-00374-4